Dexcom’s Stock Soars Amid Safety Concerns and Major Product Recall
Dexcom’s stock price is soaring, but the company’s reputation is under threat due to a Class I recall of its continuous glucose monitoring systems, citing over 1,000 reports of serious injuries.
2 minutes to read









